These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of trihydroxy propiophenone on subjective symptoms (especially in bile duct diseases)]. Miyoshi S Naika Hokan; 1967 Jun; 14(6):187-91. PubMed ID: 5624698 [No Abstract] [Full Text] [Related]
3. Choleresis & choleretics; clinical trial of 1314 CB. SCHWARTZ R Gaz Med Fr; 1958 Sep; 65(18):1473-6. PubMed ID: 13586567 [No Abstract] [Full Text] [Related]
4. [Preliminary note on our experience in the pre- and postoperative periods of biliary surgery with the 1314 CB (trimethoxy-chalcone) preparation combined with spasmolytics acting on Oddi's sphincter]. Alonso Muñoz C; Diaz Velazquez I Rev Esp Enferm Apar Dig; 1971 Nov; 35(5):559-62. PubMed ID: 5119596 [No Abstract] [Full Text] [Related]
5. [Antispasmodic treatment in biliary and colic diseases (apropos of 50 clinical cases)]. Rachail M; Bonnet-Eymard J J Med Lyon; 1966 May; 47(98):757-63. PubMed ID: 5938375 [No Abstract] [Full Text] [Related]
6. [Research on the properties of 4,2',4'-trimethoxychalone. III. Clinical study]. GUILLEMAN P; BRUNAUD M Therapie; 1958; 13(6):1042-7. PubMed ID: 13625217 [No Abstract] [Full Text] [Related]
7. Biliary tract candidiasis: diagnostic and therapeutic approaches in a case series. Domagk D; Fegeler W; Conrad B; Menzel J; Domschke W; Kucharzik T Am J Gastroenterol; 2006 Nov; 101(11):2530-6. PubMed ID: 17029620 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein in patients with gallbladder and biliary tract diseases. Vaishnavi C; Singh S; Kochhar R; Singh G; Singh K Trop Gastroenterol; 2004; 25(2):73-5. PubMed ID: 15471320 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of hydroxyacetophenone analogues on the transcytotic vesicular pathway in rat liver. Tradtrantip L; Boyer JL; Suksamrarn A; Piyachaturawat P Eur J Pharmacol; 2006 Oct; 547(1-3):152-9. PubMed ID: 16945364 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Salmonella enterica serovar typhi in bile and stool of patients with biliary diseases and those requiring biliary drainage for other purposes. Vaishnavi C; Singh S; Kochhar R; Bhasin D; Singh G; Singh K Jpn J Infect Dis; 2005 Dec; 58(6):363-5. PubMed ID: 16377868 [TBL] [Abstract][Full Text] [Related]
12. Reoperation for benign biliary tract diseases in 149 cases: causes and prevention. Liu QG; Geng ZM; Wu SL; Yao YM; Sun H; Pan CE Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):265-9. PubMed ID: 15138123 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic experiences with the myotonolytic agent, Mydocalm in angio-organopathies, angioneuropathies and angiolopathies]. Hackel F Dtsch Gesundheitsw; 1966 Jan; 21(4):171-6. PubMed ID: 5939327 [No Abstract] [Full Text] [Related]
14. Estimation of endotoxin in infected bile from patients with biliary diseases. Vaishnavi C; Kochhar R; Kaur S; Singh G Trop Gastroenterol; 2006; 27(1):22-5. PubMed ID: 16910056 [TBL] [Abstract][Full Text] [Related]
15. Suprapapillary puncture of the common bile duct for selective biliary access: a novel technique (with videos). Artifon EL; Sakai P; Ishioka S; Hondo FY; Raju GS Gastrointest Endosc; 2007 Jan; 65(1):124-31. PubMed ID: 17185091 [TBL] [Abstract][Full Text] [Related]
16. [State of the art in therapeutic biliary endoscopy]. Costamagna G; Familiari P; Iacopini F; Shah S; Marchese M Rev Gastroenterol Mex; 2005 Jul; 70 Suppl 1():63-82. PubMed ID: 17469411 [TBL] [Abstract][Full Text] [Related]
17. Origin of oxysterols in hepatic bile of patients with biliary infection. Yoshida T; Matsuzaki Y; Haigh WG; Fukushima S; Ikezawa K; Tanaka N; Lee SP Am J Gastroenterol; 2003 Oct; 98(10):2275-80. PubMed ID: 14572579 [TBL] [Abstract][Full Text] [Related]
18. [The development of biliary tract surgery]. Huang ZQ Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1585-6. PubMed ID: 17359681 [No Abstract] [Full Text] [Related]
19. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease? Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062 [TBL] [Abstract][Full Text] [Related]
20. [Study of the therapeutic value of a slow-acting ACTH (ACTH-polyphloretin phosphate)]. FERRAND M; EHRHART C; BATTESTI JP Alger Medicale; 1958 Dec; 62(12):1275-8 passim. PubMed ID: 13626773 [No Abstract] [Full Text] [Related] [Next] [New Search]